Atea Pharmaceuticals Reports Quarterly Results for June 30, 2026

What Happened

• On August 12, 2026, Atea Pharmaceuticals, Inc. (AVIR) announced its financial results for the three months ended June 30, 2026 by issuing a press release. The company furnished that press release as Exhibit 99.1 to its Current Report on Form 8-K (Item 2.02: Results of Operations and Financial Condition).

Key Details

• Press release dated August 12, 2026 announcing quarterly results.
• Results cover the three months ended June 30, 2026.
• The press release is furnished as Exhibit 99.1 and is incorporated by reference into the Form 8-K.
• The filing’s primary disclosure is the earnings/quarterly results press release (Item 2.02).

Why It Matters

• This 8-K provides Atea’s latest quarterly performance update (earnings/quarterly results) and is the official source for metrics such as revenue, net income (or loss), cash position, and management commentary—information that can influence investor decisions.
• Retail investors should review the furnished press release (Exhibit 99.1) for the specific financial figures and any commentary on business trends, as the Form 8-K itself references that release as the substantive disclosure.